Supermarket chain settles pay-for-delay suit over birth control pill
19-12-2019
FTC demands corrections in GSK, Teva pay-for-delay ruling
17-03-2016
Sebastian Duda / Shutterstock.com
The US Court of Appeals for the First Circuit has revived claims that pay-for-delay settlements involving pharmaceutical company Warner Chilcott may be in breach of competition law, despite the deals not including cash payments.
To continue reading this article and to access our full archive, digital magazines and special reports you will need a subscription.
Start a subscription today to access the LSIPR website
If you have already subscribed please login.
For multi-user price options, or to check if your company has an existing subscription we can add you into, please email Atif at achoudhury@newtonmedia.co.uk
If you have any technical issues please email tech support.
For access to the complete website and archive choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial select ‘TWO WEEK FREE TRIAL’.
US Court of Appeals for the First Circuit; Warner Chilcott; US Supreme Court; FTC v Actavis; Watson; Lupin; anti-competition; Loestrin 24
